These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35968011)
1. Characterization of the Fecal Microbiome in Dogs Receiving Medical Management for Congenital Portosystemic Shunts. Squire N; Lux C; Tolbert K; Lidbury J; Sun X; Suchodolski JS Front Vet Sci; 2022; 9():897760. PubMed ID: 35968011 [TBL] [Abstract][Full Text] [Related]
2. Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts. Favier RP; de Graaf E; Corbee RJ; Kummeling A Vet Q; 2020 Dec; 40(1):108-114. PubMed ID: 32194008 [No Abstract] [Full Text] [Related]
3. Long-term survival and quality of life in dogs with clinical signs associated with a congenital portosystemic shunt after surgical or medical treatment. Greenhalgh SN; Reeve JA; Johnstone T; Goodfellow MR; Dunning MD; O'Neill EJ; Hall EJ; Watson PJ; Jeffery ND J Am Vet Med Assoc; 2014 Sep; 245(5):527-33. PubMed ID: 25148094 [TBL] [Abstract][Full Text] [Related]
4. Hemostatic profiles in 39 dogs with congenital portosystemic shunts. Niles JD; Williams JM; Cripps PJ Vet Surg; 2001; 30(1):97-104. PubMed ID: 11172465 [TBL] [Abstract][Full Text] [Related]
5. Thromboelastographic evaluation of dogs with congenital portosystemic shunts. Kelley D; Lester C; DeLaforcade A; Webster CR J Vet Intern Med; 2013; 27(5):1262-7. PubMed ID: 23815243 [TBL] [Abstract][Full Text] [Related]
6. Comparison of diet, lactulose, and metronidazole combinations in the control of pre-surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts. Serrano G; Devriendt N; de Rooster H; Paepe D J Vet Intern Med; 2022 Jul; 36(4):1258-1266. PubMed ID: 35633289 [TBL] [Abstract][Full Text] [Related]
7. Endogenous benzodiazepine activity in the peripheral and portal blood of dogs with congenital portosystemic shunts. Aronson LR; Gacad RC; Kaminsky-Russ K; Gregory CR; Mullen KD Vet Surg; 1997; 26(3):189-94. PubMed ID: 9150556 [TBL] [Abstract][Full Text] [Related]
8. Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts. Tivers MS; Handel I; Gow AG; Lipscomb VJ; Jalan R; Mellanby RJ PLoS One; 2014; 9(1):e82303. PubMed ID: 24392080 [TBL] [Abstract][Full Text] [Related]
9. Hepatic hepcidin gene expression in dogs with a congenital portosystemic shunt. Frowde PE; Gow AG; Burton CA; Powell R; Lipscomb VJ; House AK; Mellanby RJ; Tivers MS J Vet Intern Med; 2014; 28(4):1203-5. PubMed ID: 24962818 [TBL] [Abstract][Full Text] [Related]
10. Markers of hepatic regeneration associated with surgical attenuation of congenital portosystemic shunts in dogs. Tivers MS; Lipscomb VJ; Smith KC; Wheeler-Jones CP; House AK Vet J; 2014 May; 200(2):305-11. PubMed ID: 24662025 [TBL] [Abstract][Full Text] [Related]
11. Comparison of survival after surgical or medical treatment in dogs with a congenital portosystemic shunt. Greenhalgh SN; Dunning MD; McKinley TJ; Goodfellow MR; Kelman KR; Freitag T; O'Neill EJ; Hall EJ; Watson PJ; Jeffery ND J Am Vet Med Assoc; 2010 Jun; 236(11):1215-20. PubMed ID: 20513200 [TBL] [Abstract][Full Text] [Related]
12. Markers of angiogenesis associated with surgical attenuation of congenital portosystemic shunts in dogs. Tivers MS; House AK; Smith KC; Wheeler-Jones CP; Lipscomb VJ J Vet Intern Med; 2014; 28(5):1424-32. PubMed ID: 25132501 [TBL] [Abstract][Full Text] [Related]
14. Congenital Portosystemic Shunts in Dogs and Cats: Treatment, Complications and Prognosis. Konstantinidis AO; Adamama-Moraitou KK; Patsikas MN; Papazoglou LG Vet Sci; 2023 May; 10(5):. PubMed ID: 37235429 [TBL] [Abstract][Full Text] [Related]
15. Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs. Pilla R; Gaschen FP; Barr JW; Olson E; Honneffer J; Guard BC; Blake AB; Villanueva D; Khattab MR; AlShawaqfeh MK; Lidbury JA; Steiner JM; Suchodolski JS J Vet Intern Med; 2020 Sep; 34(5):1853-1866. PubMed ID: 32856349 [TBL] [Abstract][Full Text] [Related]
16. Effects of a perioperative antibiotic and veterinary probiotic on fecal dysbiosis index in dogs. Lucchetti B; Lane SL; Koenig A; Good J; Suchodolski JS; Brainard BM Can Vet J; 2021 Mar; 62(3):240-246. PubMed ID: 33692578 [TBL] [Abstract][Full Text] [Related]
17. Association of portovenographic findings with outcome in dogs receiving surgical treatment for single congenital portosystemic shunts: 45 cases (2000-2004). Lee KC; Lipscomb VJ; Lamb CR; Gregory SP; Guitian J; Brockman DJ J Am Vet Med Assoc; 2006 Oct; 229(7):1122-9. PubMed ID: 17014361 [TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors for neurological signs after attenuation of single congenital portosystemic shunts in 253 dogs. Strickland R; Tivers MS; Adamantos SE; Harcourt-Brown TR; Fowkes RC; Lipscomb VJ Vet Surg; 2018 Aug; 47(6):745-755. PubMed ID: 30084495 [TBL] [Abstract][Full Text] [Related]
19. Serum melatonin in dogs with congenital portosystemic shunting, with and without hepatic encephalopathy. Ferreira MDF; Mellanby RJ; Gow AG Vet Rec; 2020 Aug; 187(3):e23. PubMed ID: 31974269 [TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide and toll-like receptor 4 in dogs with congenital portosystemic shunts. Tivers MS; Lipscomb VJ; Smith KC; Wheeler-Jones CP; House AK Vet J; 2015 Dec; 206(3):404-13. PubMed ID: 26383860 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]